Lucas Carrie L, Chandra Anita, Nejentsev Sergey, Condliffe Alison M, Okkenhaug Klaus
Molecular Development of the Immune System Section, Laboratory of Immunology, and Clinical Genomics Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Immunobiology Department, Yale University School of Medicine, New Haven, Connecticut 06511, USA.
Nat Rev Immunol. 2016 Nov;16(11):702-714. doi: 10.1038/nri.2016.93. Epub 2016 Sep 12.
Primary immunodeficiencies are inherited disorders of the immune system, often caused by the mutation of genes required for lymphocyte development and activation. Recently, several studies have identified gain-of-function mutations in the phosphoinositide 3-kinase (PI3K) genes PIK3CD (which encodes p110δ) and PIK3R1 (which encodes p85α) that cause a combined immunodeficiency syndrome, referred to as activated PI3Kδ syndrome (APDS; also known as p110δ-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency (PASLI)). Paradoxically, both loss-of-function and gain-of-function mutations that affect these genes lead to immunosuppression, albeit via different mechanisms. Here, we review the roles of PI3Kδ in adaptive immunity, describe the clinical manifestations and mechanisms of disease in APDS and highlight new insights into PI3Kδ gleaned from these patients, as well as implications of these findings for clinical therapy.
原发性免疫缺陷是免疫系统的遗传性疾病,通常由淋巴细胞发育和激活所需基因的突变引起。最近,几项研究在磷酸肌醇3激酶(PI3K)基因PIK3CD(编码p110δ)和PI3R1(编码p85α)中鉴定出功能获得性突变,这些突变会导致一种联合免疫缺陷综合征,称为活化PI3Kδ综合征(APDS;也称为导致衰老T细胞、淋巴结病和免疫缺陷的p110δ激活突变(PASLI))。矛盾的是,影响这些基因的功能丧失和功能获得性突变都会导致免疫抑制,尽管其机制不同。在这里,我们综述了PI3Kδ在适应性免疫中的作用,描述了APDS的临床表现和疾病机制,并强调了从这些患者身上获得的关于PI3Kδ的新见解,以及这些发现对临床治疗的意义。